Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601

Watchlist Manager
Shenzhen Kangtai Biological Products Co Ltd Logo
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
Watchlist
Price: 18.1 CNY -4.99% Market Closed
Market Cap: 20.2B CNY
Have any thoughts about
Shenzhen Kangtai Biological Products Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Shenzhen Kangtai Biological Products Co Ltd

Revenue
2.9B CNY
Cost of Revenue
-531m CNY
Gross Profit
2.4B CNY
Operating Expenses
-1.9B CNY
Operating Income
537.2m CNY
Other Expenses
-21m CNY
Net Income
516.2m CNY

Income Statement
Shenzhen Kangtai Biological Products Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
436
N/A
460
+5%
552
+20%
552
0%
816
+48%
1 006
+23%
1 161
+15%
1 419
+22%
1 756
+24%
1 867
+6%
2 017
+8%
1 955
-3%
1 761
-10%
1 911
+9%
1 943
+2%
1 779
-8%
2 006
+13%
1 969
-2%
2 261
+15%
2 361
+4%
2 443
+3%
3 218
+32%
3 652
+13%
4 247
+16%
4 428
+4%
3 840
-13%
3 157
-18%
3 034
-4%
3 060
+1%
3 057
0%
3 477
+14%
3 181
-9%
2 949
-7%
Gross Profit
Cost of Revenue
(147)
(134)
(119)
(106)
(119)
(130)
(153)
(161)
(191)
(196)
(184)
(179)
(162)
(163)
(165)
(164)
(168)
(163)
(231)
(268)
(345)
(513)
(1 136)
(1 091)
(1 089)
(974)
(774)
(503)
(507)
(531)
(653)
(528)
(531)
Gross Profit
290
N/A
326
+13%
433
+33%
445
+3%
697
+57%
877
+26%
1 008
+15%
1 257
+25%
1 565
+24%
1 671
+7%
1 833
+10%
1 777
-3%
1 599
-10%
1 748
+9%
1 779
+2%
1 616
-9%
1 838
+14%
1 807
-2%
2 031
+12%
2 093
+3%
2 098
+0%
2 706
+29%
2 516
-7%
3 156
+25%
3 339
+6%
2 865
-14%
2 384
-17%
2 531
+6%
2 553
+1%
2 526
-1%
2 824
+12%
2 652
-6%
2 418
-9%
Operating Income
Operating Expenses
(207)
(240)
(346)
(404)
(579)
(677)
(766)
(882)
(1 049)
(1 154)
(1 340)
(1 292)
(1 140)
(1 189)
(1 120)
(1 074)
(1 189)
(1 178)
(1 318)
(1 388)
(1 343)
(1 336)
(1 138)
(1 472)
(2 239)
(2 500)
(2 108)
(2 953)
(2 403)
(2 234)
(1 878)
(1 872)
(1 881)
Selling, General & Administrative
(174)
(207)
(290)
(370)
(553)
(670)
(701)
(916)
(1 079)
(1 142)
(1 149)
(1 140)
(951)
(983)
(933)
(916)
(1 023)
(1 014)
(1 052)
(1 114)
(1 078)
(1 009)
(819)
(1 025)
(1 148)
(1 284)
(1 352)
(1 327)
(1 333)
(1 313)
(1 504)
(1 441)
(1 394)
Research & Development
0
(24)
(40)
0
0
(27)
(85)
(28)
0
(51)
(167)
(156)
(201)
(219)
(189)
(206)
(212)
(215)
(243)
(299)
(307)
(347)
(324)
(384)
(569)
(713)
(745)
(791)
(707)
(579)
(457)
(524)
(476)
Depreciation & Amortization
0
(9)
(16)
0
0
0
(21)
0
0
0
(38)
0
0
0
(45)
0
0
0
(51)
0
0
0
(61)
0
0
0
(84)
0
0
0
(85)
0
0
Other Operating Expenses
(33)
0
(0)
(34)
(26)
20
40
61
31
38
14
5
12
13
46
49
46
51
28
25
43
20
65
(63)
(521)
(503)
74
(836)
(364)
(341)
169
93
(11)
Operating Income
83
N/A
86
+4%
87
+1%
42
-52%
119
+186%
200
+68%
242
+21%
375
+55%
516
+38%
517
+0%
493
-5%
485
-2%
460
-5%
560
+22%
658
+18%
542
-18%
649
+20%
628
-3%
712
+13%
705
-1%
756
+7%
1 370
+81%
1 378
+1%
1 684
+22%
1 100
-35%
365
-67%
276
-24%
(422)
N/A
150
N/A
292
+95%
946
+224%
780
-18%
537
-31%
Pre-Tax Income
Interest Income Expense
(0)
(1)
(1)
(2)
(2)
(1)
0
(1)
(1)
(2)
(11)
(12)
(12)
(11)
2
4
21
43
66
95
103
92
90
66
52
43
26
22
10
7
4
(4)
(10)
Non-Reccuring Items
(1)
0
0
0
(6)
(6)
0
(6)
0
0
(5)
0
(1)
(1)
(2)
0
(0)
0
(8)
(0)
(0)
0
(16)
0
0
0
(621)
0
1
(1)
(2)
(1)
(2)
Gain/Loss on Disposition of Assets
(1)
(1)
(0)
0
(1)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
11
13
14
20
4
3
(4)
(33)
(22)
(19)
13
5
4
0
6
4
(3)
(5)
3
(1)
(8)
(8)
(12)
(18)
(6)
(11)
(19)
(18)
(20)
(15)
(8)
(11)
(12)
Pre-Tax Income
93
N/A
98
+5%
99
+1%
59
-41%
113
+91%
193
+72%
238
+23%
334
+41%
494
+48%
497
+1%
489
-2%
477
-2%
451
-6%
548
+22%
663
+21%
549
-17%
667
+21%
667
+0%
772
+16%
799
+3%
851
+6%
1 455
+71%
1 439
-1%
1 731
+20%
1 147
-34%
398
-65%
(338)
N/A
(418)
-24%
141
N/A
283
+101%
940
+232%
764
-19%
513
-33%
Net Income
Tax Provision
(11)
(12)
(13)
(7)
(12)
(25)
(23)
(38)
(63)
(63)
(53)
(52)
(43)
(58)
(89)
(72)
(91)
(90)
(93)
(97)
(95)
(173)
(176)
(220)
(100)
33
206
218
116
78
(79)
(54)
3
Income from Continuing Operations
82
86
86
52
101
168
215
296
431
435
436
426
408
490
575
477
576
577
679
702
756
1 282
1 263
1 512
1 047
430
(133)
(201)
257
361
861
710
516
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
Net Income (Common)
82
N/A
86
+5%
86
+1%
52
-40%
101
+93%
168
+67%
215
+28%
296
+38%
431
+45%
435
+1%
436
+0%
426
-2%
408
-4%
490
+20%
575
+17%
477
-17%
576
+21%
577
+0%
679
+18%
702
+3%
756
+8%
1 282
+70%
1 263
-1%
1 512
+20%
1 047
-31%
430
-59%
(133)
N/A
(201)
-51%
257
N/A
361
+40%
861
+138%
710
-18%
516
-27%
EPS (Diluted)
0.15
N/A
0.15
N/A
0.16
+7%
0.09
-44%
0.16
+78%
0.27
+69%
0.35
+30%
0.47
+34%
0.69
+47%
0.69
N/A
0.7
+1%
0.68
-3%
0.64
-6%
0.77
+20%
0.9
+17%
0.73
-19%
0.87
+19%
0.86
-1%
1.01
+17%
1.01
N/A
0.68
-33%
1.13
+66%
1.14
+1%
1.35
+18%
0.94
-30%
1.59
+69%
-0.12
N/A
-0.17
-42%
0.23
N/A
0.32
+39%
0.77
+141%
0.64
-17%
0.46
-28%

See Also

Discover More